Logo-bi
Review

1. Advanced drug delivery and targeting technologies for the ocular diseases
Jaleh Barar ORCID, Ayuob Aghanejad, Marziyeh Fathi, Yadollah Omidi* ORCID
Bioimpacts. 2016;6(1): 49-67. doi: 10.15171/bi.2016.07
PMCID: PMC4916551     PMID: 27340624     Scopus ID: 84977080654    
Article
PDF
Full Text
XML
Cited By:
117
39
107
Original Research

2. Osteoblastic cell response to Al2O3-Ti composites as bone implant materials
Marjan Bahraminasab* ORCID, Samaneh Arab, Somaye Ghaffari
BioImpacts. 2022;12(3): 247-259. doi: 10.34172/bi.2021.2330
PMCID: PMC9124877     PMID: 35677667     Scopus ID: 85132130879    
Article
PDF
Full Text
XML
Cited By:
6
0
1
Our in-vitro findings demonstrated that the 75Ti, 50Ti, and 25Ti composites havehigh potential to be used as load-bearing orthopedic materials.
Review

3. Intraocular drug delivery systems for Diabetic retinopathy: Current and future prospective
Sayed Latif Taheri ORCID, Safoora Poorirani, Sayed Abolfazl Mostafavi* ORCID
Bioimpacts. 2025;15: 30127 | Published on: 2024 May 19. doi: 10.34172/bi.30127
Article
PDF
XML
Cited By:
0

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge